Targeting the gut microbiome to treat metabolic dysfunction- associated fatty liver disease: ready for prime time?

HIGHLIGHTS

  • who: Nicolas Lanthier and Nathalie Delzenne from the Laboratory of Gastroenterology and Hepatology, Institut de Recherche Expu00e9rimentale et Clinique have published the article: Targeting the Gut Microbiome to Treat Metabolic Dysfunction- Associated Fatty Liver Disease: Ready for Prime Time?, in the Journal: Cells 2022, 11, 2718. of /2022/
  • what: The gut-liver axis is clearly established from extensive mechanistic studies in animals and in humans.
  • how: The authors have to mention that in 2021 the International Scientific Association of Probiotics and Prebiotics decided to change the definition of postbiotics and to apply the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?